by Gemma Escarré,
usMIMA, a start-up that specialises in designing and selling medical devices to combat chronic constipation, has launched a crowdfunding campaign to raise €400,000 on the Capital Cell platform. It is a bridge round, currently led by Genesis Ventures with €50,000, which will lead into a Series A round in late 2019.
The first product the company has developed is called Mowoot, a device that stimulates intestinal transit naturally, based on a clear need, identified by patients and doctors. Chronic constipation affects 250 million people around the world, but there are few innovative solutions on the market.
With this funding, Mowoot aims to consolidate its expansion in Europe and complete certification with the US Food Drug Administration (FDA), while negotiating international distribution and licensing agreements. Currently, more than 1,000 units have been sold in countries including Spain, the United Kingdom and Germany.
Photo: Mowoot was created under the framework of the Biocat d•Health fellowship programme and validated the product’s clinical efficacy at Institut Guttman
We recommend this video of CataloniaBio & HealthTech interviewing the CEO when the company joined the association: